APDN - アプライドDNAサイエンシス (Applied DNA Sciences Inc) アプライドDNAサイエンシス



symbol APDN
会社名 Applied DNA Sciences Inc (アプライドDNAサイエンシス)
分野(sector) Consumer Services   消費者サービス
産業(industry) Other Consumer Services  
業種 化学_特殊化学製品   工業(Industrials)
概要 事業概要 Applied DNA Sciences Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA SigNature T DNA fiberTyping DNAnet digitalDNA SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company''s platform ingredient at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.   アプライドDNAサイエンシスは、米国のDNAセキュリティ―ソリュ―ション会社。製品、ブランド、知的財産権の偽造や転用を防ぐため、北米と欧州で、DNAタグを利用した偽造防止技術を供給する。主な製品は、「SigNatureDNA」、「fiberTyping」、「 DNANet」、 「digitalDNA」など。本社は、ニューヨーク州スト―ニ―ブルック。   Applied DNA Sciences Inc creates security solutions addressing the challenges of supply chain security, brand protection or law enforcement applications.
本社所在地 50 Health Sciences Drive Stony Brook NY 11790 USA
代表者氏名 James A. Hayward ジェームズ・A・ヘイワード
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 631-240-8800
設立年月日 1983年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 60人
url www.adnas.com
nasdaq_url https://www.nasdaq.com/symbol/apdn
EBITDA EBITDA(百万ドル) -10.19729
終値(lastsale) 1.42
時価総額(marketcap) 42759120.94
時価総額 時価総額(百万ドル) 43.36136
売上高 売上高(百万ドル) 3.85349
企業価値(EV) 企業価値(EV)(百万ドル) 40.84654
当期純利益 当期純利益(百万ドル) -11.07232
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Applied DNA Sciences Inc revenues decreased 25% to $2.7M. Net loss decreased 18% to $8.2M. Revenues reflect United States (Country) segment decrease of 58% to $1.1M Europe segment decrease of 17% to $799K. Lower net loss reflects Selling general and administrative decrease of 29% to $7.5M (expense) Depreciation and amortization decrease of 13% to $426K (expense).



   Applied DNA and GHCL Launch "REKOOP" Verified by the CertainT Platform on Amazon.com on Earth Day  2019-04-22 Business Wire
CertainT Verified Recycled PET Bedding Drives Sustainabilityfor Global E-commerce Applied DNA Sciences Inc. (NASDAQ: APDN) , a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, and GHCL announced today the launch of REKOOP…
   B. Riley FBR sees 65% upside in Deciphera Pharma in premarket analyst action  2018-12-31
UniQure (NASDAQ: QURE ), Tocagen (NASDAQ: TOCA ), Iovance Biotherapeutics (NASDAQ: IOVA ) and Miragen Therapeutics (NASDAQ: MGEN ) all resumed with Buy ratings at B. Riley FBR. More news on: uniQure N.V., Tocagen Inc, Iovance Biotherapeutics, Inc., Healthcare stocks news, , Tech stocks new…

 関連キーワード  (化学_特殊化学製品 米国株 アプライドDNAサイエンシス APDN Applied DNA Sciences Inc)


 twitter  (公式ツイッターやCEOツイッターなど)